Status:
UNKNOWN
Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation
Lead Sponsor:
Klinikum Klagenfurt am Wörthersee
Collaborating Sponsors:
Medical University of Graz
Conditions:
Glaucoma
Progression
Eligibility:
All Genders
18-100 years
Brief Summary
The trabeculectomy is the gold standard in glaucoma surgery, nevertheless often postoperative interventions have to be done. (1),(2) The PreserFlo MicroShunt (Santen, Osaka, Japan) implantation occurs...
Eligibility Criteria
Inclusion
- Patients with insufficient eye pressure control despite IOP (intraocular pressure)-lowering therapy
- Diagnosis of POAG (primary open angle glaucoma)
- Diagnosis of PEG (pseudoexfoliation glaucoma)
- Diagnosis of PDG (pigment dispersion glaucoma)
- Diagnosis of NTG (normal tension glaucoma)
- Agreement of patients to participate in the study
Exclusion
- Previous glaucoma surgery
- Visual acuity of Nulla Lux
- Poor general condition
- Pregnancy
- Exudative macular degeneration
Key Trial Info
Start Date :
October 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 9 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06174324
Start Date
October 12 2021
End Date
September 9 2024
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KlinikumKlagenfurt
Klagenfurt, Austria, 9020